30.5.2007
•
News
M&A
KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Law firm Kocián Šolc Balaštík represented Indian pharmaceutical company Glenmark Pharmaceuticals Ltd. in concluding a deal via its Swiss subsidiary Glenmark Holding SA to acquire a majority shareholding in Medicamenta a.s., a company carrying out business activities in the production, sale and marketing of pharmaceutical products in the Czech Republic and Slovakia.
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
7.4.2025
•
News
KŠB is the official partner of the Smetanova Litomyšl Festival
We are delighted to announce that we have become an official partner of one of the most important cultural projects in the Czech Republic – the Smetanova Litomyšl music festival. With the title “ the law firm of the festival", we are proud to be part of this long-standing social event that blends music with a unique historical setting.
